Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-3122023-04-01falsetrueNo description of principal activity2trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12376470 2023-04-01 2024-03-31 12376470 2022-01-01 2023-03-31 12376470 2024-03-31 12376470 2023-03-31 12376470 c:Director1 2023-04-01 2024-03-31 12376470 c:RegisteredOffice 2023-04-01 2024-03-31 12376470 d:OfficeEquipment 2023-04-01 2024-03-31 12376470 d:OfficeEquipment 2024-03-31 12376470 d:OfficeEquipment 2023-03-31 12376470 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 12376470 d:ComputerSoftware 2024-03-31 12376470 d:ComputerSoftware 2023-03-31 12376470 d:OtherResidualIntangibleAssets 2023-04-01 2024-03-31 12376470 d:CurrentFinancialInstruments 2024-03-31 12376470 d:CurrentFinancialInstruments 2023-03-31 12376470 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 12376470 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 12376470 d:ShareCapital 2024-03-31 12376470 d:ShareCapital 2023-03-31 12376470 d:RetainedEarningsAccumulatedLosses 2024-03-31 12376470 d:RetainedEarningsAccumulatedLosses 2023-03-31 12376470 d:AcceleratedTaxDepreciationDeferredTax 2024-03-31 12376470 d:AcceleratedTaxDepreciationDeferredTax 2023-03-31 12376470 c:OrdinaryShareClass1 2023-04-01 2024-03-31 12376470 c:OrdinaryShareClass1 2024-03-31 12376470 c:OrdinaryShareClass1 2023-03-31 12376470 c:FRS102 2023-04-01 2024-03-31 12376470 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 12376470 c:FullAccounts 2023-04-01 2024-03-31 12376470 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12376470 d:ComputerSoftware d:InternallyGeneratedIntangibleAssets 2023-04-01 2024-03-31 12376470 2 2023-04-01 2024-03-31 12376470 d:ComputerSoftware d:OwnedIntangibleAssets 2023-04-01 2024-03-31 12376470 e:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 12376470









MEDINDEX LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
MEDINDEX LTD
 
 
COMPANY INFORMATION


Director
Dr P Freeman 




Registered number
12376470



Registered office
18a/20 King Street

Maidenhead

Berkshire

SL6 1EF




Accountants
Donald Reid Limited

18a/20 King Street

Maidenhead

Berkshire

SL6 1DT





 
MEDINDEX LTD
 

CONTENTS



Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8


 
MEDINDEX LTD
REGISTERED NUMBER: 12376470

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
26,097
27,313

Tangible assets
 5 
435
295

  
26,532
27,608

Current assets
  

Debtors: amounts falling due within one year
 6 
2,511
3,370

Cash at bank and in hand
 7 
18,156
38,302

  
20,667
41,672

Creditors: amounts falling due within one year
 8 
(16,158)
(32,875)

Net current assets
  
 
 
4,509
 
 
8,797

Total assets less current liabilities
  
31,041
36,405

Provisions for liabilities
  

Deferred tax
 9 
(83)
(56)

  
 
 
(83)
 
 
(56)

Net assets
  
30,958
36,349


Capital and reserves
  

Called up share capital 
 10 
1
1

Profit and loss account
  
30,957
36,348

  
30,958
36,349


Page 1

 
MEDINDEX LTD
REGISTERED NUMBER: 12376470
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 18 November 2024.




Dr P Freeman
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
MEDINDEX LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Medindex Ltd  is a private company limited by shares. The company was incorporated in the United Kingdom and registered in England and Wales. The registration number is 12376470. The registered office is 18a/20 King Street, Maidenhead, Berkshire, United Kingdom, SL6 1EF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

  
2.2

Reporting Period

The comparative financial statements were prepared for a 15 month period from 1 January 2022
to 31 March 2023. The directors believe 31 March to be a more appropriate year end date. As a result, the comparative figures (including the related notes), are not entirely comparable. The change of accounting reference date, as approved by the board of directors, was filed with the Registrar of Companies.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 3

 
MEDINDEX LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.7

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Computer software
-
10
years

 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
MEDINDEX LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)


2.8
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.12

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 5

 
MEDINDEX LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Intangible assets




Computer software

£



Cost


At 1 April 2023
31,327


Additions - internal
2,000



At 31 March 2024

33,327



Amortisation


At 1 April 2023
4,014


Charge for the year on owned assets
3,216



At 31 March 2024

7,230



Net book value



At 31 March 2024
26,097



At 31 March 2023
27,313



Page 6

 
MEDINDEX LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

5.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 April 2023
337


Additions
229



At 31 March 2024

566



Depreciation


At 1 April 2023
42


Charge for the year on owned assets
89



At 31 March 2024

131



Net book value



At 31 March 2024
435



At 31 March 2023
295


6.


Debtors

2024
2023
£
£


Trade debtors
1,890
-

Prepayments and accrued income
621
3,370

2,511
3,370



7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
18,156
38,302

18,156
38,302


Page 7

 
MEDINDEX LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
5,324
17,976

Other taxation and social security
1,608
1,149

Other creditors
9,226
13,000

Accruals and deferred income
-
750

16,158
32,875



9.


Deferred taxation




2024


£






At beginning of year
(56)


Charged to profit or loss
(27)



At end of year
(83)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(83)
(56)

(83)
(56)


10.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



10 (2023 - 10) Ordinary shares of £0.10 each
1
1



11.


Related party transactions

At the year end and included within other creditors, is an amount of £9,226 (2023: £13,000) owed by
the company to the director

 
Page 8